C. Tumiotto

发表

Feasibility of convalescent plasma therapy in severe COVID‐19 patients with persistent SARS‐CoV‐2 viremia

O. Guisset, P. Bellecave, F. Bonnet, 2021, Journal of medical virology.

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values

S. Alizon, S. Burrel, A. de Rougemont, 2021, medRxiv.

Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients.

H. Fleury, P. Bellecave, P. Recordon-Pinson, 2018, AIDS research and human retroviruses.

Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles

M. Soares, C. Brander, M. Sajadi, 2019, PloS one.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

C. Charpentier, Y. Yazdanpanah, D. Costagliola, 2022, BMC Infectious Diseases.

Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

M. Beadsworth, D. Hamer, P. Kozarsky, 2022, The Lancet. Infectious diseases.

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020

S. Alizon, S. Burrel, A. de Rougemont, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Rapid Adenovirus typing method for species identification.

H. Wodrich, F. Rayne, M. Lafon, 2017, Journal of virological methods.

Clinical and biological features of enteroviral meningitis among adults and children and factors associated with severity and length of stay.

D. Neau, A. Desclaux, M. Lafon, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Modulation of the functional interfaces between retroviral intasomes and the human nucleosome

H. Munier-Lehmann, O. Delelis, E. Mauro, 2022, bioRxiv.

Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75

C. Zimmer, J. Toutain, C. Rooryck, 2021, Nucleic acids research.

High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection

P. Morlat, P. Bellecave, F. Bonnet, 2017, The Journal of antimicrobial chemotherapy.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus

S. Hughes, J. Mellors, J. Coffin, 2020, bioRxiv.

Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA

R. Siliciano, L. Montaner, J. Blankson, 2020, Proceedings of the National Academy of Sciences.

Comparison of methods to quantify inducible HIV-1 outgrowth

J. Mellors, J. Eron, R. Gandhi, 2021, Journal of virus eradication.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France

H. Wodrich, D. Malvy, P. Trimoulet, 2022, Journal of Clinical Virology.

Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis

V. Appay, E. Lazaro, R. Rossignol, 2023, AIDS.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort

D. Neau, E. Lazaro, P. Bellecave, 2020, Open forum infectious diseases.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Phylogenetic analysis of HIV-1 archived DNA in blood and gut-associated lymphoid tissue in patients receiving antiretroviral therapy: a study from Provir/Latitude45 project

M. Soares, J. Routy, H. Fleury, 2020, bioRxiv.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA

H. Fleury, P. Bellecave, P. Recordon-Pinson, 2017, PloS one.

Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV)

V. Gaborieau, D. Breilh, D. Neau, 2023, BMC Infectious Diseases.

A Simple and Fast Method to Sequence the Full-Length Spike Gene for SARS-CoV-2 Variant Identification from Patient Samples

P. Bellecave, M. Métifiot, M. Andreola, 2021, COVID.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study

V. de Lédinghen, D. Neau, S. Pédeboscq, 2023, Scientific reports.